I'm most confused by the UK. They ran a large scale trial, they approved Astrazeneca(while the FDA has not), Novavax ran an ad in UK papers, the ComCov and ComCov2 UK trials are just out, and you'd think they would prefer to be seen as a leader in this case rather than an EU follower.

An approval from the UK would make a lot of sense unless maybe the UK is waiting on a sufficient amount of physical vaccines in country to approve....

either way, there is clearly missing information we don't know - all we have are a ton of tea leaves that tell us it should all be fine. We'll see....in the interim we keep getting hit with shrapnel every few hours from all different directions.$Novavax(NVAX)$ $AstraZeneca Plc(AZNCF)$